
CLEV'ALIGN
AI-powered software for orthodontists to automate treatment planning and enable in-clinic aligner printing.
About
CLEV'ALIGN develops AI-powered software designed to streamline the orthodontic treatment planning process. Their solution automates complex tasks, allowing orthodontists to create treatment plans more efficiently and enables the in-clinic printing of clear aligners, reducing turnaround time and costs.
Similar companies
AI-powered platform for 3D-printed patient-specific surgical instruments at scale.
Shares Healthcare, MedTech
AI-powered surgical planning for precise, personalized patient outcomes.
Shares Healthcare, HealthTech
AI platform automating healthcare phone calls to improve patient access and care coordination.
Shares Healthcare, HealthTech
AI-powered diagnostic system for predictive analytics in healthcare.
Shares Healthcare, HealthTech
AI-powered video health data platform for remote vital sign monitoring via smartphone.
Shares Healthcare, HealthTech
Develops an augmented reality surgical headset and digital platform for enhanced surgical visualization and navigation.
Shares Healthcare, MedTech
Key facts
- Website
- merrypal.com
- Headquarters
- Tel Aviv, Israel
- Founded
- 2020
- Employees
- 7
- Business model
- B2B
Tech stack
Detected on merrypal.com, last scanned 30 Oct 2026. Run your own scan
- Observability
- Sentry
- CMS / Builders
- Wix
- CDN
- Cloudflare
Test your Ahrefs DR
The backlink strength of a domain, on the Ahrefs 0 to 100 scale. About a minute.
Frequently asked
Is CLEV'ALIGN trustworthy and reputable?
StartupHub's Data Trust & Reputation score for CLEV'ALIGN is 64 out of 100, a generally safe rating, based on site security posture, privacy practices, malware and phishing checks, and public reputation signals.
How many employees does CLEV'ALIGN have?
CLEV'ALIGN has approximately 7 people on record.
SEC filings, insider activity, nonprofit links and pay benchmarks for CLEV'ALIGN:
Company details: from public sources. Funding: no announced round on file. Ownership: not yet claimed by the company. Scores: measured by named tools; each links to its method. Our rules


